Attached files

file filename
EX-31.3 - EX-31.3 - CYTOKINETICS INCcytk-ex313_7.htm
EX-31.2 - EX-31.2 - CYTOKINETICS INCcytk-ex312_6.htm
EX-31.1 - EX-31.1 - CYTOKINETICS INCcytk-ex311_8.htm
EX-10.1 - EX-10.1 - CYTOKINETICS INCcytk-ex101_12.htm
10-Q - 10-Q - CYTOKINETICS INCcytk-10q_20180630.htm

Exhibit 32.1

PURSUANT TO

18. U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of Cytokinetics, Incorporated on Form 10-Q for the quarterly period ended June 30, 2018 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Form 10-Q fairly presents in all material respects the financial condition and results of operations of Cytokinetics, Incorporated.

Dated: August 7, 2018

 

 

/s/ Robert I. Blum

 

Robert I. Blum

 

President and Chief Executive Officer

(Principal Executive Officer)

 

 

 

/s/ Ching Jaw

 

Ching Jaw

 

Senior Vice President, Chief Financial Officer

(Principal Financial Officer)

 

 

 

/s/ Peter S. Roddy

 

Peter S. Roddy

 

Senior Vice President, Chief Accounting Officer

(Principal Accounting Officer)